Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis

Author(s):  
Heart Asia ◽  
2012 ◽  
Vol 4 (1) ◽  
pp. 27-30 ◽  
Author(s):  
Amit Malviya ◽  
Sundeep Mishra ◽  
Shyam S Kothari

2007 ◽  
Vol 54 (3,4) ◽  
pp. 354-358 ◽  
Author(s):  
Sara Simeoni ◽  
Antonio Puccetti ◽  
Marco Chilosi ◽  
Elisa Tinazzi ◽  
Daniele Prati ◽  
...  

Breast Cancer ◽  
2009 ◽  
Vol 17 (4) ◽  
pp. 306-309 ◽  
Author(s):  
Nikolaos S. Salemis ◽  
Georgios Nakos ◽  
Dimitrios Sambaziotis ◽  
Stavros Gourgiotis

2011 ◽  
pp. P1-722-P1-722
Author(s):  
Chiara Diazzi ◽  
Alessandro Guidi ◽  
Alessandra Luberto ◽  
Erica Taliani ◽  
Bruno Madeo ◽  
...  

Urology ◽  
2011 ◽  
Vol 77 (6) ◽  
pp. 1339-1340 ◽  
Author(s):  
Dominik Abt ◽  
Diego De Lorenzi ◽  
Wolfgang Nagel ◽  
Hans-Peter Schmid ◽  
Stefan Preusser

2007 ◽  
Vol 89 ◽  
pp. 123-142 ◽  
Author(s):  
Alvin H. Crawford ◽  
Shital Parikh ◽  
Elizabeth K. Schorry ◽  
Diane Von Stein

2005 ◽  
Vol 87 (2) ◽  
pp. 399-403
Author(s):  
PANAYIOTIS J. PAPAGELOPOULOS ◽  
ANDREAS F. MAVROGENIS ◽  
EVANTHIA C. GALANIS ◽  
GEORGE D. CHLOROS ◽  
KLEO TH. PAPAPARASKEVA

Pachychoroid neovasculopathy (PNV) is a novel clinical entity with typical pachychoroid features accompanied by type 1 choroidal neovascularization (CNV). Typical optical coherence tomography finding of the disease is flat irregular pigment epithelial detachments (double layer sign). Type 1 CNV between retinal pigment epithelium and Bruch membrane is seen as a tangled network on optical coherence tomography angiography. Differential diagnosis of PNV from neovascular age-related macular degeneration is especially important because of the different epidemiological, genetic, and therapeutic features of these diseases. Current treatment approaches include intravitreal anti-vascular endothelial growth factor injections and photodynamic therapy.


Sign in / Sign up

Export Citation Format

Share Document